Plain-English translation of NCT07553637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with treatment-resistant depression—a type of depression that hasn't improved even after trying multiple other antidepressants. Researchers will compare how well this medication works compared to a placebo (a pill with no active ingredient) in reducing depression symptoms.
Many people with depression find that standard antidepressants don't work well enough for them. This trial exists to see whether this medication might offer relief for those who have struggled to find an effective treatment.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to take either or a placebo while continuing your current antidepressant medication. Neither you nor the research team will know which you're receiving. You'll have regular visits with the research team to monitor your depression symptoms and overall health, and researchers will track how you respond to the treatment over time.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
United States